Key result
Surgical treatment for chronic thromboembolic pulmonary hypertension was associated with higher 1- and 3-year survival (88% and 76%) compared to nonsurgical management (82% and 70%; P=0.023).
Why the study?
What is the prognosis and survival of patients with chronic thromboembolic pulmonary hypertension treated medically versus surgically?
Cohort (n=469)
Yes
What is the prognosis and survival of patients with chronic thromboembolic pulmonary hypertension treated medically versus surgically?
Prognosis for both medically and surgically treated CTEPH has improved, with good long-term survival even in patients with persistent pulmonary hypertension post-surgery.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Condliffe et al. (2008) conducted a cohort in Chronic thromboembolic pulmonary hypertension (n=469). Surgical treatment vs. Nonsurgical management was evaluated on 3-year survival from diagnosis (p=0.023). Surgical treatment for chronic thromboembolic pulmonary hypertension was associated with higher 1- and 3-year survival (88% and 76%) compared to nonsurgical management (82% and 70%; P=0.023).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: